Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled ambroxol hydrochloride for sticky sputum in pediatric lower respiratory tract infection
ChiCTR2300072466Phase 3Completed
- Sponsor
- Beijing Children's Hospital
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ambroxol in pulmonary infection (2 arms), sponsored by Beijing Children's Hospital. Primary endpoint: cough. Started Jun 2023; status: completed.
02
Drugs
ambroxol
03
Conditions
pulmonary infection
Beyond the preview
Go deeper on ChiCTR2300072466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300072466.